Literature DB >> 12787262

Gene expression of cytochrome P450 1B1 and 2D6 in leukocytes in human pregnancy.

Anna-Britta Lind1, Mia Wadelius, Elisabeth Darj, Niklas Finnström, Stefan Lundgren, Anders Rane.   

Abstract

We investigated the influence of human pregnancy on gene expression of two cytochrome P450 enzymes in white blood cells. Cytochrome P450 1B1 (CYP1B1) catalyses oestradiol 4-hydroxylation, and may participate in the endocrine regulation of oestrogens. Cytochrome P450 2D6 (CYP2D6) metabolises many commonly used drugs, and previous studies have suggested that it is induced during pregnancy. CYP1B1 and CYP2D6 were therefore considered to be of interest in human pregnancy. As it is not ethically possible to take liver biopsies from healthy mothers during pregnancy, easily accessible cells that express the genes were used as a surrogate tissue. White blood cells were collected from eighteen pregnant women, and were used to measure CYP1B1 and CYP2D6 ribonucleic acid (RNA). The analysis was repeated after pregnancy, the women, thus, serving as their own controls. Real-time reverse transcriptase - polymerase chain reaction methods were used with 18S ribosomal RNA as an internal control. A slight, but not significant, increase in gene activity of CYP1B1 was detected during pregnancy. Expression of CYP2D6 in blood was extremely low, and induction of CYP2D6 during pregnancy could not be confirmed. In conclusion, gene expression of CYP1B1 and CYP2D6 in leukocytes was not significantly up-regulated in the third trimester of pregnancy, but a trend indicating an altered metabolism during pregnancy was detected.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12787262     DOI: 10.1034/j.1600-0773.2003.920607.x

Source DB:  PubMed          Journal:  Pharmacol Toxicol        ISSN: 0901-9928


  4 in total

1.  Anatomical, physiological and metabolic changes with gestational age during normal pregnancy: a database for parameters required in physiologically based pharmacokinetic modelling.

Authors:  Khaled Abduljalil; Penny Furness; Trevor N Johnson; Amin Rostami-Hodjegan; Hora Soltani
Journal:  Clin Pharmacokinet       Date:  2012-06-01       Impact factor: 6.447

Review 2.  Dopamine, morphine, and nitric oxide: an evolutionary signaling triad.

Authors:  George B Stefano; Richard M Kream
Journal:  CNS Neurosci Ther       Date:  2009-11-13       Impact factor: 5.243

3.  Transgenic overexpression of Tcfap2c/AP-2gamma results in liver failure and intestinal dysplasia.

Authors:  Daniel Holl; Peter Kuckenberg; Tatiana Woynecki; Angela Egert; Astrid Becker; Sebastian Huss; Dirk Stabenow; Andreas Zimmer; Percy Knolle; René Tolba; Hans-Peter Fischer; Hubert Schorle
Journal:  PLoS One       Date:  2011-07-13       Impact factor: 3.240

4.  Association between CYP2D6 Genotypes and the Risk of Antidepressant Discontinuation, Dosage Modification and the Occurrence of Maternal Depression during Pregnancy.

Authors:  Anick Bérard; Andrea Gaedigk; Odile Sheehy; Christina Chambers; Mark Roth; Pina Bozzo; Diana Johnson; Kelly Kao; Sharon Lavigne; Lori Wolfe; Dee Quinn; Kristen Dieter; Jin-Ping Zhao
Journal:  Front Pharmacol       Date:  2017-07-17       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.